| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047277709 |
| P356 | DOI | 10.1038/SJ.GT.3301529 |
| P698 | PubMed publication ID | 11571569 |
| P5875 | ResearchGate publication ID | 11775851 |
| P50 | author | Deborah Young | Q54994045 |
| Bridget Dicker | Q58692334 | ||
| P2093 | author name string | Chen Q | |
| Ma H | |||
| During MJ | |||
| Janson CG | |||
| Leone P | |||
| Choi KL | |||
| Xu R | |||
| Dragunow M | |||
| Lawlor P | |||
| Fitzsimons H | |||
| Mastakov M | |||
| Mouravlev A | |||
| P2860 | cites work | Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions | Q24531466 |
| A system for the propagation of adenoviral vectors with genetically modified receptor specificities | Q30630915 | ||
| Dressing up adenoviruses to modify their tropism.. Interview by Florence Paillard | Q31431773 | ||
| Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo | Q34070164 | ||
| Selective and rapid uptake of adeno-associated virus type 2 in brain | Q34471578 | ||
| Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS | Q34472181 | ||
| Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. | Q34486856 | ||
| AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection | Q34486863 | ||
| Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. | Q35111738 | ||
| Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. | Q36634983 | ||
| Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector | Q36663364 | ||
| Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. | Q39580820 | ||
| Subcellular compartmentalization of adeno-associated virus type 2 assembly | Q39878164 | ||
| Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts | Q40016714 | ||
| A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid | Q40954235 | ||
| Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression | Q40972848 | ||
| Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus | Q41052074 | ||
| Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein | Q41226028 | ||
| Gene transfer by adeno-associated virus vectors into the central nervous system | Q41450710 | ||
| Gene transfer into mammalian central nervous system using herpes virus vectors: extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter | Q41601982 | ||
| Efficient CFTR expression from AAV vectors packaged with promoters--the second generation | Q41688873 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Sequences in the proximal 5' flanking region of the rat neuron-specific enolase (NSE) gene are sufficient for cell type-specific reporter gene expression | Q42435600 | ||
| Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. | Q42466029 | ||
| Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: lack of an RGD integrin-binding motif | Q42596109 | ||
| Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. | Q42609041 | ||
| Differential effects of polyadenylation regions on gene expression in mammalian cells | Q43800430 | ||
| Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
| Adeno-associated virus 2 co-receptors? | Q45749672 | ||
| Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses | Q45749766 | ||
| Peroral gene therapy of lactose intolerance using an adeno-associated virus vector | Q45753463 | ||
| Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors | Q45756988 | ||
| The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors | Q45763222 | ||
| Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters | Q45764253 | ||
| Quantitative analysis of the packaging capacity of recombinant adeno-associated virus | Q45766162 | ||
| Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
| AAVant-garde gene therapy | Q45855547 | ||
| Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity | Q45857095 | ||
| Optimization of plasmid vectors for high-level expression in lung epithelial cells | Q45881255 | ||
| In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector | Q45889326 | ||
| Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control | Q46168479 | ||
| Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease | Q48389936 | ||
| Transgene expression of plasmid DNAs directed by viral or neural promoters in the rat brain | Q48696315 | ||
| Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes. | Q52202136 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice | Q56896435 | ||
| Expression and distribution of functional integrins in rat CNS glia | Q71679515 | ||
| The cell bodies of origin of sympathetic and sensory axons in some skin and muscle nerves of the cat hindlimb | Q71709723 | ||
| Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoter | Q72251144 | ||
| Dopaminergic regulation of a transfected preproenkephalin promoter in primary rat astrocytes in vitro and in vivo | Q72572610 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1323-1332 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes | |
| P478 | volume | 8 |
| Q89568541 | A MicroRNA-Based Gene-Targeting Tool for Virally Labeling Interneurons in the Rodent Cortex |
| Q42252512 | A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons. |
| Q45857343 | A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury |
| Q34684652 | A single intravenous AAV9 injection mediates bilateral gene transfer to the adult mouse retina |
| Q35114530 | AAV-mediated overexpression of neuroserpin in the hippocampus decreases PSD-95 expression but does not affect hippocampal-dependent learning and memory. |
| Q39409371 | Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. |
| Q92069614 | Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation |
| Q44762877 | Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior |
| Q35216648 | Adeno-associated viral vectors. |
| Q30497101 | Adeno-associated virus (AAV)-mediated suppression of Ca2+/calmodulin kinase IV activity in the nucleus accumbens modulates emotional behaviour in mice |
| Q45730269 | Adeno-associated virus-mediated gene transfer to the neonatal brain |
| Q30605561 | Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy |
| Q44814719 | Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. |
| Q40275505 | Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter |
| Q36381023 | Avian adeno-associated virus vector efficiently transduces neurons in the embryonic and post-embryonic chicken brain |
| Q57114151 | Bile diversion, a bariatric surgery, and bile acid signaling reduce central cocaine reward |
| Q38812342 | Cell-Specific Targeting of Genetically Encoded Tools for Neuroscience |
| Q34898869 | Comparison of the efficacy of four viral vectors for transducing hypothalamic magnocellular neurosecretory neurons in the rat supraoptic nucleus |
| Q35853990 | Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids. |
| Q90575182 | Corticostriatal stimulation compensates for medial frontal inactivation during interval timing |
| Q28580955 | Cytoglobin overexpression protects against damage-induced fibrosis |
| Q90354293 | DNA Editing Enzymes as Potential Treatments for Heteroplasmic mtDNA Diseases |
| Q37237181 | Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice |
| Q48560197 | Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice |
| Q33731243 | Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates |
| Q43764350 | Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. |
| Q44385521 | Distinct patterns of gene transfer to gerbil hippocampus with recombinant adeno-associated virus type 2 and 5. |
| Q48526007 | Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream. |
| Q42503430 | Ectopic expression of TrKA in the adult rat basal ganglia induces both nerve growth factor-dependent and -independent neuronal responses |
| Q33713108 | Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. |
| Q34862612 | Engineered lentiviral vector targeting astrocytes in vivo |
| Q48380900 | Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. |
| Q37341395 | Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome |
| Q34987213 | Gene delivery to the eye using adeno-associated viral vectors |
| Q35340196 | Gene therapy for the nervous system: challenges and new strategies |
| Q37938886 | Genetic approaches to investigate the role of CREB in neuronal plasticity and memory. |
| Q36720557 | Hypothalamic EphA5 facilitates counterregulatory responses: possible role for bidirectional signaling leading to bistability that enhances responsiveness to hypoglycemia |
| Q36290118 | Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain. |
| Q35000819 | Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain |
| Q37718180 | Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina |
| Q44219031 | Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats |
| Q41780807 | Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin |
| Q45856196 | Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice |
| Q42199204 | Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters |
| Q34318553 | Long-term follow-up after gene therapy for canavan disease. |
| Q40692823 | Measurements of vector-derived neurotrophic factor and green fluorescent protein levels in the brain |
| Q35902332 | Methods for gene transfer to the central nervous system |
| Q36425890 | Non-viral therapeutic approaches to ocular diseases: An overview and future directions |
| Q34997364 | Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity |
| Q37684186 | Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons |
| Q33185069 | Particle detection, number estimation, and feature measurement in gene transfer studies: optical fractionator stereology integrated with digital image processing and analysis |
| Q35009241 | Preferential lentiviral targeting of astrocytes in the central nervous system |
| Q34987192 | Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain |
| Q40616143 | Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development |
| Q34987182 | Recombinant adeno-associated virus vector design and gene expression in the mammalian brain |
| Q34987187 | Regulation of gene expression in adeno-associated virus vectors in the brain |
| Q44719583 | Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. |
| Q33586314 | Restricted transgene expression in the brain with cell-type specific neuronal promoters |
| Q42401422 | Select overexpression of homer1a in dorsal hippocampus impairs spatial working memory |
| Q34448297 | Somatic gene transfer of cAMP response element-binding protein attenuates memory impairment in aging rats |
| Q36631977 | Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity |
| Q48218703 | Stereotaxic gene delivery in the rodent brain |
| Q40643169 | Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. |
| Q90971001 | Systemic AAV vectors for widespread and targeted gene delivery in rodents |
| Q37028654 | Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model. |
| Q37711706 | Targeted CNS Delivery Using Human MiniPromoters and Demonstrated Compatibility with Adeno-Associated Viral Vectors. |
| Q37238775 | Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies. |
| Q37356520 | Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide |
| Q38004089 | The advent of AAV9 expands applications for brain and spinal cord gene delivery |
| Q36337994 | The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration |
| Q40554074 | Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. |
| Q40585361 | Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids |
| Q28578381 | VEGF links hippocampal activity with neurogenesis, learning and memory |
| Q34285870 | Versatile somatic gene transfer for modeling neurodegenerative diseases |
| Q38338190 | Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy |
| Q30495981 | Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expression |
| Q34446026 | Viral-based gene transfer to the mammalian CNS for functional genomic studies |
| Q89878841 | rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application |
Search more.